Loading data
VENUNYSE
| Unit: USD | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | 17.9 m USD | 17.83 m USD | 12.6 m USD |
| Operating profit | -46.13 m USD | -27.38 m USD | -11.13 m USD |
| Profit before tax | -50.78 m USD | -32.79 m USD | -11.39 m USD |
| Net income (reported basis) | -44.09 m USD | -30.34 m USD | -10.52 m USD |
| Basic earnings per share | -1.1 USD/share | -0.86 USD/share | — |
| Diluted earnings per share | -1.1 USD/share | -0.86 USD/share | — |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.